Related Experiment Videos
Treatment of anaerobic infections: an overview
Abstract:
Increasing resistance on the part of anaerobes to several antimicrobial agents has been a problem in recent years. Mechanisms of resistance include production of inactivating enzymes such as beta-lactamases, plasmid-mediated transferable resistance and failure of the drug to penetrate the bacterial cell. Fortunately, availability of several new agents permits us to treat anaerobic infections effectively. However, it is now desirable to do routine in vitro susceptibility testing of anaerobes, especially in seriously ill patients. Newly introduced drugs and others still undergoing study are compared with the standard agents.
Insights
Anaerobic bacteria are increasingly resistant to antimicrobial drugs. Routine susceptibility testing is recommended for serious infections, comparing new and standard agents for effective treatment.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Increasing antimicrobial resistance in anaerobic bacteria poses a significant clinical challenge.
- Mechanisms of resistance include enzyme production (e.g., beta-lactamases), plasmid transfer, and reduced drug penetration.
- Effective treatment of anaerobic infections is crucial, especially in immunocompromised or critically ill patients.
Purpose of the Study:
- To evaluate the in vitro susceptibility of anaerobic bacteria to various antimicrobial agents.
- To compare the efficacy of newly introduced and investigational drugs against standard treatments.
- To emphasize the importance of routine susceptibility testing for guiding therapy.
Main Methods:
- In vitro susceptibility testing of anaerobic isolates.
- Comparison of multiple antimicrobial agents, including novel and established drugs.
- Analysis of resistance mechanisms relevant to anaerobic pathogens.
Main Results:
- Data comparing the effectiveness of different antimicrobial agents against anaerobic bacteria.
- Identification of specific resistance patterns and mechanisms.
- Evaluation of the utility of new agents in overcoming existing resistance.
Conclusions:
- Routine in vitro susceptibility testing of anaerobes is highly desirable, particularly for severe infections.
- New antimicrobial agents show promise in treating infections caused by resistant anaerobes.
- Ongoing surveillance and testing are essential for managing anaerobic bacterial resistance.